Soleno Therapeutics Inc (SLNO) support and resistance · P/E 27, $2.76B cap
Soleno Therapeutics Inc (SLNO) is a biotechnology company listed on NASDAQ.
This page maps Soleno Therapeutics Inc (SLNO) support and resistance from cached range and valuation — not a live tape and not a trade alert.
SLNO income-statement cache is thin, so levels here lean on the stock page until the next filing lands.
SLNO currently screens at market cap $2.76B and trailing P/E 27.5. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new SLNO 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the SLNO quote page for the session range and the stock page for the full model.
Not investment advice.